Matching-adjusted indirect comparison (MAIC) of efficacy and safety outcomes for lisocabtagene maraleucel (liso-cel) versus axicabtagene ciloleucel (axi-cel) and tisagenlecleucel (tisa-cel) for the treatment of third-line or later (3L+) relapsed or refractory (R/R) follicular lymphoma (FL) Meeting Abstract
| Authors: | Boardman, A. P.; Reguera, J. L.; Spin, P.; Wang, P.; Almuallem, L.; Ellis, J.; Zheng, J.; Kumar, J.; Farazi, T.; García-Sancho, A. M.; Izutsu, K. |
| Abstract Title: | Matching-adjusted indirect comparison (MAIC) of efficacy and safety outcomes for lisocabtagene maraleucel (liso-cel) versus axicabtagene ciloleucel (axi-cel) and tisagenlecleucel (tisa-cel) for the treatment of third-line or later (3L+) relapsed or refractory (R/R) follicular lymphoma (FL) |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 3028 |
| Language: | English |
| ACCESSION: | WOS:001415684800024 |
| DOI: | 10.1182/blood-2024-197948 |
| PROVIDER: | wos |
| Notes: | Source: Wos |
